Suscripción a Biblioteca: Guest
Critical Reviews™ in Immunology

Publicado 6 números por año

ISSN Imprimir: 1040-8401

ISSN En Línea: 2162-6472

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 1.3 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 2.6 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00079 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.24 SJR: 0.429 SNIP: 0.287 CiteScore™:: 2.7 H-Index: 81

Indexed in

Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes

Volumen 38, Edición 5, 2018, pp. 343-365
DOI: 10.1615/CritRevImmunol.2018026750
Get accessGet access

SINOPSIS

Programming of inflammation resolution is governed by a class of specialized pro-resolving lipid mediators (SPMs) that act in concert to modulate epithelial, endothelial, and immune cell function for restoration of homeostasis. The resolution circuits are altered in obesity and associated morbidities, including type 2 diabetes mellitus (T2D), through reduced production and/or action of SPMs, which can be rescued by therapeutic SPM delivery or up-regulation of SPM receptors. Resolvin E1 (RvE1), an eicosapentaenoic acid derivative, has potent pro-resolving and insulin-sensitizing actions mediated by BLT1 and ERV1 receptors in the vasculature and metabolic organs. Nonetheless, the RvE1-mediated increase in protective adipokines such as adiponectin in white adipose tissues, the enhancement of monocyte patrolling function in the vasculature, as well as the macrophage-clearing functions improve metabolic control in obese-prone conditions. RvE1-enhanced resolving function in obesity prevents dysbiosis of the gut microflora and increased gut permeability. These functions suggest that RE1 has therapeutic potential for immunometabolic alterations associated with T2D in patients with reduced inflammation resolving capacity. SPM profiling in individuals at risk for T2D and associated complications will help to advance personalized disease management and precision medicine.

CITADO POR
  1. Doyle Ross, Godson Catherine, Brennan Eoin, Promoting resolution in kidney disease, Current Opinion in Nephrology and Hypertension, 29, 1, 2020. Crossref

  2. Sima Corneliu, Viniegra Ana, Glogauer Michael, Macrophage immunomodulation in chronic osteolytic diseases—the case of periodontitis, Journal of Leukocyte Biology, 105, 3, 2019. Crossref

  3. Livshits Gregory, Kalinkovich Alexander, Inflammaging as a common ground for the development and maintenance of sarcopenia, obesity, cardiomyopathy and dysbiosis, Ageing Research Reviews, 56, 2019. Crossref

  4. Bruschi Maurizio, Santucci Laura, Petretto Andrea, Bartolocci Martina, Marchisio Marco, Ghiggeri Gian Marco, Verrina Enrico, Ramenghi Luca A., Panfoli Isabella, Candiano Giovanni, Association between maternal omega‐3 polyunsaturated fatty acids supplementation and preterm delivery: A proteomic study, The FASEB Journal, 34, 5, 2020. Crossref

  5. Xia Fangbo, He Chengwei, Ren Meng, Xu Feng-Guo, Wan Jian-Bo, Quantitative profiling of eicosanoids derived from n-6 and n-3 polyunsaturated fatty acids by twin derivatization strategy combined with LC-MS/MS in patients with type 2 diabetes mellitus, Analytica Chimica Acta, 1120, 2020. Crossref

  6. Desoye G., Herrera E., Adipose tissue development and lipid metabolism in the human fetus: The 2020 perspective focusing on maternal diabetes and obesity, Progress in Lipid Research, 81, 2021. Crossref

  7. Herrera Vielma Francisca, Valenzuela Rodrigo, Videla Luis A., Zúñiga-Hernández Jessica, N-3 Polyunsaturated Fatty Acids and Their Lipid Mediators as A Potential Immune–Nutritional Intervention: A Molecular and Clinical View in Hepatic Disease and Other Non-Communicable Illnesses, Nutrients, 13, 10, 2021. Crossref

  8. Yang Ailin, Wu Yanjun, Yu Ganggang, Wang Haoyan, Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development, Respiratory Research, 22, 1, 2021. Crossref

  9. Diaz-Rubio Gustavo Ignacio, Corona-Meraz Fernanda-Isadora, Madrigal-Ruiz Perla-Monserrat, Robles-De Anda Jesús-Aureliano, Gómez-Bañuelos Eduardo, Castro-Albarran Jorge, Flores-Alvarado Luis-Javier, Vázquez-Del Mercado Mónica, Pérez-Vázquez Felipe de Jesús, Pizano-Martínez Oscar-Enrique, Navarro-Hernández Rosa-Elena, Sánchez-Margalet Víctor, CCR2/CCL2 and CMKLR1/RvE1 chemokines system levels are associated with insulin resistance in rheumatoid arthritis, PLOS ONE, 16, 1, 2021. Crossref

  10. Dasilva Gabriel, Lois Salomé, Méndez Lucía, Miralles-Pérez Bernat, Romeu Marta, Ramos-Romero Sara, Torres Josep L., Medina Isabel, Fish Oil Improves Pathway-Oriented Profiling of Lipid Mediators for Maintaining Metabolic Homeostasis in Adipose Tissue of Prediabetic Rats, Frontiers in Immunology, 12, 2021. Crossref

  11. Al-Shaer Abrar E., Pal Anandita, Shaikh Saame Raza, Resolvin E1-ChemR23 Axis Regulates the Hepatic Metabolic and Inflammatory Transcriptional Landscape in Obesity at the Whole Genome and Exon Level, Frontiers in Nutrition, 8, 2021. Crossref

  12. Shofler David, Rai Vikrant, Mansager Sarah, Cramer Kira, Agrawal Devendra K., Impact of resolvin mediators in the immunopathology of diabetes and wound healing, Expert Review of Clinical Immunology, 17, 6, 2021. Crossref

  13. Shimizu Tomohiko, Saito Tsugumichi, Aoki‐Saito Haruka, Okada Shuichi, Ikeda Hiroyuki, Nakakura Takashi, Fukuda Hayato, Arai Syota, Fujiwara Kouichi, Nakajima Yasuyo, Horiguchi Kazuhiro, Yamada Sayaka, Ishida Emi, Hisada Takeshi, Shuto Satoshi, Yamada Masanobu, Resolvin E3 ameliorates high‐fat diet‐induced insulin resistance via the phosphatidylinositol‐3‐kinase/Akt signaling pathway in adipocytes, The FASEB Journal, 36, 3, 2022. Crossref

  14. Liakh Ivan, Janczy Agata, Pakiet Alicja, Korczynska Justyna, Proczko-Stepaniak Monika, Kaska Lukasz, Sledzinski Tomasz, Mika Adriana, One-anastomosis gastric bypass modulates the serum levels of pro- and anti-inflammatory oxylipins, which may contribute to the resolution of inflammation, International Journal of Obesity, 46, 2, 2022. Crossref

  15. Morita Yoshifumi, Kurano Makoto, Sakai Eri, Sawabe Motoji, Aoki Junken, Yatomi Yutaka, Simultaneous analyses of urinary eicosanoids and related mediators identified tetranor-prostaglandin E metabolite as a novel biomarker of diabetic nephropathy, Journal of Lipid Research, 62, 2021. Crossref

  16. Livshits Gregory, Kalinkovich Alexander, Specialized, Pro-Resolving Mediators as Potential Therapeutic Agents for Alleviating Fibromyalgia Symptomatology, Pain Medicine, 23, 5, 2022. Crossref

  17. Quach Su Sheng, Zhu Alan, Lee Ryan S. B., Seymour Gregory J., Immunomodulation—What to Modulate and Why? Potential Immune Targets, Frontiers in Dental Medicine, 3, 2022. Crossref

  18. Zhao Zewei, Liu Siqi, Qian Bingxiu, Zhou Lin, Shi Jianglin, Liu Junxi, Xu Lin, Yang Zhonghan, CMKLR1 senses chemerin/resolvin E1 to control adipose thermogenesis and modulate metabolic homeostasis, Fundamental Research, 2022. Crossref

  19. Al‐Shaer Abrar E., Pal Anandita, Shi Qing, Carson Meredith S., Regan Jennifer, Behee Madeline, Buddenbaum Nicole, Drawdy Catie, Davis Traci, Virk Rafia, Shaikh Saame Raza, Modeling human heterogeneity of obesity with diversity outbred mice reveals a fat mass‐dependent therapeutic window for resolvin E1, The FASEB Journal, 36, 6, 2022. Crossref

  20. Pal Anandita, Al‐Shaer Abrar E., Guesdon William, Torres Maria J., Armstrong Michael, Quinn Kevin, Davis Traci, Reisdorph Nichole, Neufer P. Darrell, Spangenburg Espen E., Carroll Ian, Bazinet Richard P., Halade Ganesh V., Clària Joan, Shaikh Saame Raza, Resolvin E1 derived from eicosapentaenoic acid prevents hyperinsulinemia and hyperglycemia in a host genetic manner, The FASEB Journal, 34, 8, 2020. Crossref

  21. Tajbakhsh Amir, Gheibihayat Seyed Mohammad, Karami Neda, Savardashtaki Amir, Butler Alexandra E., Rizzo Manfredi, Sahebkar Amirhossein, The regulation of efferocytosis signaling pathways and adipose tissue homeostasis in physiological conditions and obesity: Current understanding and treatment options, Obesity Reviews, 23, 10, 2022. Crossref

  22. Cai Jiazheng, Liu Jing, Yan Jing, Lu Xuexia, Wang Xiaoli, Li Si, Mustafa Kamal, Wang Huihui, Xue Ying, Mustafa Manal, Kantarci Alpdogan, Xing Zhe, Impact of Resolvin D1 on the inflammatory phenotype of periodontal ligament cell response to hypoxia , Journal of Periodontal Research, 57, 5, 2022. Crossref

  23. Barden Anne E., Shinde Sujata, Phillips Michael, Beilin Lawrence J., Mori Trevor A., Mediators of inflammation resolution and vasoactive eicosanoids in gestational diabetes and preeclampsia, Journal of Hypertension, 40, 11, 2022. Crossref

  24. Zhang Jiawei, Liu Lan, Zhang Yaxuan, Yuan Yuan, Miao Zhijuan, Lu Kaili, Zhang Xiaojie, Ni Ruiqing, Zhang Haibing, Zhao Yuwu, Wang Xiuzhe, ChemR23 signaling ameliorates cognitive impairments in diabetic mice via dampening oxidative stress and NLRP3 inflammasome activation, Redox Biology, 58, 2022. Crossref

Próximos Artículos

Identification of key chondrocyte apoptosis-related genes in osteoarthritis based on weighted gene co-expression network analysis and experimental verification Wei Wang, Junyi Hong, Tianyi Cao, Fusheng Ye, Junwei Gao, Shumei Qin Anoikis and Mitophagy-Related Gene Signature for Predicting the Survival and Tumor Cell Progression in Colon Cancer Jian Shen, Minzhe Li Exploring the mechanism of Isoforskolin against asthma based on network pharmacology and experimental verification Yan Fang, Shibo Sun, Chuang Xiao, Min Li, Yuanyuan Zheng, Anju Zu, Zhuang Luo Identification of a novel five-gene prognostic model for laryngeal cancer associated with mitophagy using integrated bioinformatics analysis and experimental verification Dong Song, Lun Dong, Mei Wang, Xiaoping Gao Function of steroid receptor coactivators (SRCs) in T cells and cancers: Implications for cancer immunotherapy Wencan Zhang, Xu Cao, Hongmin Wu, Xiancai Zhong, Yun Shi, Zuoming Sun Electroacupuncture Alleviates Ischemic Stroke by Activating the mTOR/SREBP1 Pathway Jiawang Lang, Jianchang Luo, Luodan Wang, Wenbin Xu, Jie Jia, Zhipeng Zhao, Boxu Lang KIAA1429 induces the m6A modification of LINC01106 to enhance the malignancy of lung adenocarcinoma cell via JAK/STAT3 pathway Di Xu, Ziming Wang, Fajiu Li Effects of different doses of dexmedetomidine on the prevention of postoperative sleep disturbance and serum neurotransmitter level in patients under general anesthesia Huifei Lu, Fei He, Ying Huang, Zhongliang Wei
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones Precios y Políticas de Suscripcione Begell House Contáctenos Language English 中文 Русский Português German French Spain